Recruiting
A Clinical Trial of EHT102 Injection in Pediatric Patients With Biallelic hOTOF Mutations
NCT07288580
- Conditions
- Treatment of Congenital Hearing Loss Secondary to Biallelic Mutations of the Otoferlin Gene (OTOF)
- Locations
-
- Eye & ENT Hospital of Fudan University Shanghai, Shanghai Municipality, China